The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies
暂无分享,去创建一个
Rassoul Dinarvand | Mahdi Gholami | R. Dinarvand | M. Rouini | Mohammad-Reza Rouini | Maryam Dibaei | Behjat Sheikholeslami | M. Gholami | B. Sheikholeslami | M. Dibaei
[1] R. Müller,et al. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns , 2005, Journal of drug targeting.
[2] Sahdeo Prasad,et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases , 2017, British journal of pharmacology.
[3] P. Flecknell,et al. Experimental and surgical technique in the rat. , 1980 .
[4] A. O. Kamel,et al. Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery – comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution , 2017, Drug delivery.
[5] F. Cui,et al. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] M. Bououdina,et al. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles , 2017, Artificial cells, nanomedicine, and biotechnology.
[7] P. Wei,et al. Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery , 2011, International journal of nanomedicine.
[8] H. Thu,et al. Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy , 2018, Trends in Food Science & Technology.
[9] T. Maekawa,et al. Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease , 2012, PloS one.
[10] B. Hyman,et al. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model , 2007, Journal of neurochemistry.
[11] Xinguo Jiang,et al. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. , 2006, International journal of pharmaceutics.
[12] Jian-sheng Liu,et al. Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier , 2017, Scientific Reports.
[13] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[14] B. Aggarwal,et al. Curcumin as "Curecumin": from kitchen to clinic. , 2008, Biochemical pharmacology.
[15] Ajazuddin,et al. Recent advancements in liposomes targeting strategies to cross blood‐brain barrier (BBB) for the treatment of Alzheimer's disease , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[16] Eknath D. Ahire,et al. Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications , 2018, Acta pharmaceutica Sinica. B.
[17] Robert A Newman,et al. Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.
[18] B. Aggarwal,et al. Curcumin and cancer: an "old-age" disease with an "age-old" solution. , 2008, Cancer letters.
[19] X. Wu,et al. Nanotechnological advances for the delivery of CNS therapeutics. , 2012, Advanced drug delivery reviews.
[20] R. Müller,et al. Kinetic solubility and dissolution velocity of rutin nanocrystals. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[21] Jun Li,et al. Distribution of an intravenous injectable nimodipine nanosuspension in mice , 2008, The Journal of pharmacy and pharmacology.
[22] P. Couvreur,et al. Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery , 2001, Pharmaceutical Research.
[23] Xiaoli Liu,et al. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions. , 2013, International journal of pharmaceutics.
[24] J. Kreuter,et al. Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.
[25] Probal Banerjee,et al. Curcumin blocks brain tumor formation , 2009, Brain Research.
[26] Kenneth S Suslick,et al. Sonocrystallization and sonofragmentation. , 2014, Ultrasonics sonochemistry.
[27] Rainer H Müller,et al. State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[28] Farooq Ali Khan,et al. Nanoemulsion: Concepts, development and applications in drug delivery , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[29] K. Bayne,et al. An Overview of Global Legislation, Regulation, and Policies on the Use of Animals for Scientific Research, Testing, or Education , 2002 .
[30] Sanjay Garg,et al. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery. , 2009, International journal of pharmaceutics.
[31] H. Thu,et al. Nanoencapsulation, an efficient and promising approach to maximize wound healing efficacy of curcumin: A review of new trends and state-of-the-art. , 2017, Colloids and surfaces. B, Biointerfaces.
[32] S. Kulkarni,et al. Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier. , 2011, Nanomedicine.
[33] Peter Ramge,et al. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.
[34] V. Vogel,et al. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[35] Wei Wu,et al. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization. , 2012, International journal of pharmaceutics.
[36] J. Kreuter,et al. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[37] Lei Tao,et al. Design and development of novel hyaluronate-modified nanoparticles for combo-delivery of curcumin and alendronate: fabrication, characterization, and cellular and molecular evidences of enhanced bone regeneration. , 2018, International journal of biological macromolecules.
[38] R. Müller,et al. Development of curcumin nanocrystal: physical aspects. , 2013, Journal of pharmaceutical sciences.
[39] Rainer H Müller,et al. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[40] Ying Zheng,et al. Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution. , 2017, Nanomedicine : nanotechnology, biology, and medicine.
[41] W. Lu,et al. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. , 2005, International journal of pharmaceutics.
[42] Barrett E. Rabinow,et al. Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.
[43] R. Müller,et al. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. , 2000, International journal of pharmaceutics.
[44] Wei He,et al. Globular protein-coated Paclitaxel nanosuspensions: interaction mechanism, direct cytosolic delivery, and significant improvement in pharmacokinetics. , 2015, Molecular pharmaceutics.
[45] Aiguo Li,et al. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer , 2010, Drug development and industrial pharmacy.
[46] Supriya Shidhaye,et al. Advances in polymeric micelles for drug delivery and tumor targeting. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[47] K. Chopra,et al. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[48] A. Mishra,et al. Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain. , 2013, International journal of pharmaceutics.
[49] J. Carlson. Animal Research Ethics , 2014 .
[50] Raviraj M. Kulkarni,et al. Nanosuspensions: a promising drug delivery strategy , 2004, The Journal of pharmacy and pharmacology.
[51] H. Rachmawati,et al. TPGS-Stabilized Curcumin Nanoparticles Exhibit Superior Effect on Carrageenan-Induced Inflammation in Wistar Rat , 2016, Pharmaceutics.
[52] Si-Shen Feng,et al. Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery , 2013, Pharmaceutical Research.
[53] Si-Shen Feng,et al. Vitamin E TPGS as a molecular biomaterial for drug delivery. , 2012, Biomaterials.
[54] Raquel Ferreira,et al. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[55] Lin Sun,et al. Effects of nanosuspension formulations on transport, pharmacokinetics, in vivo targeting and efficacy for poorly water-soluble drugs. , 2014, Current pharmaceutical design.
[56] Chee Wee Gan,et al. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. , 2010, Biomaterials.
[57] Yong Zhang,et al. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..
[58] Kinzo Matsumoto,et al. Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acid-induced neurotoxic responses in the rat hippocampus. , 2007, Biological & pharmaceutical bulletin.
[59] U. Olsson,et al. Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[60] P. Constantinides,et al. Advances in lipid nanodispersions for parenteral drug delivery and targeting. , 2008, Advanced drug delivery reviews.
[61] Ying Zheng,et al. Stability of nanosuspensions in drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.